Pacific Biosciences of California, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $137.9M
Liabilities Breakdown FY2016
Total Liabilities: $53.2M
Asset Breakdown
Total Assets: $137.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $16.8M | 12.2% |
| Accounts Receivable | $11.4M | 8.3% |
| Inventory | $15.6M | 11.3% |
| Property, Plant & Equipment | $14.6M | 10.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $79.5M | 57.7% |
Liabilities Breakdown
Total Liabilities: $53.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.4M | 15.7% |
| Long-Term Debt | $16.1M | 30.3% |
| Other Liabilities | $28.8M | 54.0% |